Achmea Investment Management’s Boston Scientific BSX Stock Holding History

Achmea Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-234,655	Closed	-$22.9M	–	146
2025 Q3	$22.9M	Hold	234,655	–	–	0.28%	106
2025 Q2	$25.2M	Buy	234,655 +34,600	+17%	+$3.5M	0.33%	82
2025 Q1	$20.2M	Buy	200,055 +59,682	+43%	+$6.01M	0.29%	102
2024 Q4	$12.5M	Buy	140,373 +67,362	+92%	+$5.93M	0.21%	132
2024 Q3	$6.12M	Buy	73,011 +9,431	+15%	+$743K	0.1%	207
2024 Q2	$4.9M	Hold	63,580	–	–	0.09%	216
2024 Q1	$4.36M	Hold	63,580	–	–	0.08%	237
2023 Q4	$3.67M	Hold	63,580	–	–	0.08%	253
2023 Q3	$3.36M	Buy	63,580 +8,259	+15%	+$433K	0.07%	254
2023 Q2	$2.99M	Buy	55,321 +38,141	+222%	+$1.99M	0.06%	293
2023 Q1	$859K	Hold	17,180	–	–	0.02%	406
2022 Q4	$745K	Hold	17,180	–	–	0.03%	437
2022 Q3	$665K	Hold	17,180	–	–	0.02%	449
2022 Q2	$640K	Hold	17,180	–	–	0.02%	463
2022 Q1	$761K	Hold	17,180	–	–	0.02%	483
2021 Q4	$730K	Hold	17,180	–	–	0.03%	276
2021 Q3	$745K	Buy	+17,180	New	+$760K	0.02%	475
2019 Q1	–	Sell	-12,216	Closed	-$432K	–	435
2018 Q4	$432K	Buy	+12,216	New	+$443K	0.02%	395

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Achmea Investment Management's BSX Position: Q4 2025 in Review

Achmea Investment Management sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 234,655 shares — an estimated $22.9M sold.

Achmea Investment Management first reported a position in BSX in Q4 2018 and held it in 18 quarters. The position peaked at $25.2M in Q2 2025. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Achmea Investment Management reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Achmea Investment Management sold 234,655 Boston Scientific shares in Q4 2025, an estimated $22.9M.
Achmea Investment Management first reported a position in Boston Scientific in Q4 2018 and held it in 18 quarters.
Achmea Investment Management's Boston Scientific position peaked at $25.2M in Q2 2025.
1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Achmea Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.